{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:22:03Z","timestamp":1777897323798,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008386","name":"Marmara \u00dcniversitesi","doi-asserted-by":"publisher","award":["ADT-2022-1061"],"award-info":[{"award-number":["ADT-2022-1061"]}],"id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008982","name":"Qatar National Research Fund","doi-asserted-by":"publisher","award":["PPM 05-0419-210008"],"award-info":[{"award-number":["PPM 05-0419-210008"]}],"id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jaip.2026.01.009","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:41:30Z","timestamp":1769560890000},"page":"907-919.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SPINK5 Variants Drive Clinical Variability in Netherton Syndrome Through Th2\/Th17 Skewing and Influence Therapeutic Outcomes"],"prefix":"10.1016","volume":"14","author":[{"given":"Melek","family":"Yorgun Altunbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erhan","family":"Topal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feyza","family":"Bayram-Catak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Cihangir","family":"Catak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razin","family":"Amirov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkay Cagan","family":"Colak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asena P\u0131nar","family":"Sefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Can","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necmiye","family":"Keser-Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selcen","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Mahmudov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alper","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durmus Burak","family":"Demirkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernice","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevgi","family":"Bilgic-Eltan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Karakoc-Aydiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe Deniz","family":"Y\u00fccelten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4730-9422","authenticated-orcid":false,"given":"Safa","family":"Baris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.01.009_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/75977","article-title":"Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome","volume":"25","author":"Chavanas","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2026.01.009_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jaip.2022.10.003","article-title":"The Middle East and North Africa diagnosis and management guidelines for inborn errors of immunity","volume":"11","author":"Baris","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.009_bib3","article-title":"Skin of atopic dermatitis patients shows disturbed \u03b2-glucocerebrosidase and acid sphingomyelinase activity that relates to changes in stratum corneum lipid composition","volume":"1865","author":"Boer","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.jaip.2026.01.009_bib4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.0022-202X.2005.23838.x","article-title":"Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity","volume":"125","author":"Hachem","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2026.01.009_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaci.2016.07.019","article-title":"An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis","volume":"139","author":"Paller","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.009_bib6","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jaad.2020.07.054","article-title":"Duality of Netherton syndrome manifestations and response to ixekizumab","volume":"84","author":"Barbieux","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2026.01.009_bib7","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/hmg\/ddg247","article-title":"LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome","volume":"12","author":"Bitoun","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaip.2026.01.009_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/21678707.2020.1857724","article-title":"Advances in understanding of Netherton syndrome and therapeutic implications","volume":"8","author":"Petrova","year":"2020","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/j.jaip.2026.01.009_bib9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Comel-Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.009_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jamadermatol.2015.5827","article-title":"Intrafamily and interfamilial phenotype variation and immature immunity in patients with Netherton syndrome and Finnish SPINK5 founder mutation","volume":"152","author":"Hannula-Jouppi","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2026.01.009_bib11","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jaci.2021.08.024","article-title":"Netherton syndrome subtypes share IL-17\/IL-36 signature with distinct IFN-\u03b1 and allergic responses","volume":"149","author":"Barbieux","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.009_bib12","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/all.14197","article-title":"Comel-Netherton syndrome: a local skin barrier defect in the absence of an underlying systemic immunodeficiency","volume":"75","author":"Stuvel","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.009_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/08923973.2015.1115518","article-title":"A case of Netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels","volume":"38","author":"Yalcin","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.jaip.2026.01.009_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.864449","article-title":"Outcomes of systemic treatment in children and adults with Netherton syndrome: a systematic review","volume":"13","author":"Nouwen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.01.009_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.645259","article-title":"Netherton syndrome in children: management and future perspectives","volume":"9","author":"Barbati","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2026.01.009_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.1074243","article-title":"Biological treatments for pediatric Netherton syndrome","volume":"10","author":"Pontone","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2026.01.009_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jaip.2026.01.009_bib18","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the Universal Protein Knowledgebase in 2023","volume":"51","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaip.2026.01.009_bib19","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/jid.2011.174","article-title":"Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis","volume":"131","author":"Fortugno","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2026.01.009_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40291-016-0243-y","article-title":"Netherton syndrome: a genotype-phenotype review","volume":"21","author":"Sarri","year":"2017","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jaip.2026.01.009_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis","volume":"10","author":"Hanifin","year":"2001","journal-title":"EASI Evaluator Group. Exp Dermatol"},{"key":"10.1016\/j.jaip.2026.01.009_bib22","first-page":"23","article-title":"Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis","volume":"186","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2026.01.009_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/bjd.21615","article-title":"The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): a clinical outcome measure for the severity of atopic dermatitis","volume":"187","author":"Simpson","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2026.01.009_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjd.17744","article-title":"Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis","volume":"181","author":"Yosipovitch","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2026.01.009_bib25","series-title":"Symposium of Allergic Diseases and Treatment in Clinical Immunology, Antalya, Turkey","article-title":"The validity and reliability of the Turkish version of the Family Dermatology Life Quality Index","year":"2011"},{"key":"10.1016\/j.jaip.2026.01.009_bib26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2133.2006.07617.x","article-title":"The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease","volume":"156","author":"Basra","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2026.01.009_bib28","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/all.12429","article-title":"EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.009_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2026.01.009_bib30","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.jaci.2023.08.004","article-title":"Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency","volume":"152","author":"Taghizade","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.009_bib31","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jaci.2024.11.032","article-title":"Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease","volume":"155","author":"Bayram Catak","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.009_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10875-024-01682-0","article-title":"Rapamycin controls lymphoproliferation and reverses T-cell responses in a patient with a novel STIM1 loss-of-function deletion","volume":"44","author":"Karakus","year":"2024","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.009_bib33","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1111\/all.15331","article-title":"Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency","volume":"77","author":"Catak","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.009_bib34","article-title":"The role of SPINK5 mutation distribution in phenotypes of Netherton syndrome","volume":"16","author":"Xu","year":"2025","journal-title":"Front Genet"},{"key":"10.1016\/j.jaip.2026.01.009_bib35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1468-3083.2009.03459.x","article-title":"'Matchstick' eyebrow hairs: a dermoscopic clue to the diagnosis of Netherton syndrome","volume":"24","author":"Goujon","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2026.01.009_bib36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1523-1747.2002.01603.x","article-title":"Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families","volume":"118","author":"Bitoun","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2026.01.009_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s42003-024-05780-y","article-title":"Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways","volume":"7","author":"Petrova","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.jaip.2026.01.009_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7408967","article-title":"Insights into the roles of B cells in patients with sepsis","volume":"2023","author":"Dong","year":"2023","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaip.2026.01.009_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.imlet.2023.03.003","article-title":"IgD(\u2013)CD27(\u2013) double negative (DN) B cells: origins and functions in health and disease","volume":"255","author":"Beckers","year":"2023","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaip.2026.01.009_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2026.01.009_bib41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fimmu.2017.00174","article-title":"Follicular T cells from smB(\u2013) common variable immunodeficiency patients are skewed toward a Th1 phenotype","volume":"8","author":"Cunill","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.01.009_bib42","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41590-019-0472-4","article-title":"Follicular regulatory T cells control humoral and allergic immunity by restraining early B cell responses","volume":"20","author":"Clement","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2026.01.009_bib43","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.immuni.2022.10.009","article-title":"An embarrassment of riches: ROR\u03b3t+ antigen-presenting cells in peripheral tolerance","volume":"55","author":"Stephen-Victor","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2026.01.009_bib44","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41586-022-05309-5","article-title":"Novel antigen-presenting cell imparts Treg\u2013dependent tolerance to gut microbiota","volume":"610","author":"Akagbosu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2026.01.009_bib45","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41586-022-05089-y","article-title":"A ROR\u03b3t+ cell instructs gut microbiota-specific Treg cell differentiation","volume":"610","author":"Kedmi","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2026.01.009_bib46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaci.2023.09.025","article-title":"Regulatory T cells in dominant immunologic tolerance","volume":"153","author":"Georgiev","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.009_bib47","doi-asserted-by":"crossref","first-page":"195ra94","DOI":"10.1126\/scitranslmed.3006448","article-title":"TGF\u03b2 receptor mutations impose a strong predisposition for human allergic disease","volume":"5","author":"Frischmeyer-Guerrerio","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2026.01.009_bib48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20161435","article-title":"ERBIN deficiency links STAT3 and TGF-\u03b2 pathway defects with atopy in humans","volume":"214","author":"Lyons","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaip.2026.01.009_bib49","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/imr.12028","article-title":"Th9 cells: differentiation and disease","volume":"252","author":"Kaplan","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2026.01.009_bib50","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","article-title":"Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation","volume":"75","author":"Le Floc'h","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.009_bib51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2026.01.009_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1054422","article-title":"Dupilumab improves clinical symptoms in children with Netherton syndrome by suppressing Th2-mediated inflammation","volume":"13","author":"Yan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.01.009_bib53","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1111\/ajd.14234","article-title":"Successful infliximab treatment in siblings with Netherton syndrome: unveiling a novel SPINK5 gene variant and literature review","volume":"65","author":"Salici","year":"2024","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaip.2026.01.009_bib54","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/pde.14590","article-title":"Infliximab therapy in an infant with Netherton syndrome","volume":"38","author":"Cicek","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2026.01.009_bib55","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jaad.2024.07.1513","article-title":"A combination therapy with secukinumab and dupilumab in Netherton syndrome: a prospective pilot study","volume":"91","author":"Liu","year":"2024","journal-title":"J Am Acad Dermatol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:55:08Z","timestamp":1777625708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826000450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2213219826000450"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.009","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SPINK5 Variants Drive Clinical Variability in Netherton Syndrome Through Th2\/Th17 Skewing and Influence Therapeutic Outcomes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}